These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 7668161

  • 1. The cellular basis for opioid-induced immunosuppression.
    Guan L, Townsend R, Eisenstein TK, Adler MW, Rogers TJ.
    Adv Exp Med Biol; 1995; 373():57-64. PubMed ID: 7668161
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD, Eisenstein TK, Geller EB, Adler MW, Rogers TJ.
    Proc Natl Acad Sci U S A; 1991 Jan 15; 88(2):360-4. PubMed ID: 1846441
    [Abstract] [Full Text] [Related]

  • 5. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H, Maixner W.
    J Pharmacol Exp Ther; 1993 Feb 15; 264(2):648-53. PubMed ID: 7679733
    [Abstract] [Full Text] [Related]

  • 6. kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.
    Gurwell JA, Duncan MJ, Maderspach K, Stiene-Martin A, Elde RP, Hauser KF.
    Brain Res; 1996 Oct 21; 737(1-2):175-87. PubMed ID: 8930364
    [Abstract] [Full Text] [Related]

  • 7. Mouse strain differences in in vivo and in vitro immunosuppressive effects of opioids.
    Eisenstein TK, Meissler JJ, Bussiere JL, Rogers TJ, Geller EB, Adler MW.
    Adv Exp Med Biol; 1995 Oct 21; 373():115-21. PubMed ID: 7668141
    [No Abstract] [Full Text] [Related]

  • 8. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG, West DC, Headley PM.
    NIDA Res Monogr; 1986 Oct 21; 75():461-4. PubMed ID: 2828992
    [Abstract] [Full Text] [Related]

  • 9. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG, West DC, Headley PM.
    Br J Pharmacol; 1989 Oct 21; 98(2):533-43. PubMed ID: 2555012
    [Abstract] [Full Text] [Related]

  • 10. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
    Barrett AC, Cook CD, Terner JM, Roach EL, Syvanthong C, Picker MJ.
    Psychopharmacology (Berl); 2002 Mar 21; 160(2):170-81. PubMed ID: 11875635
    [Abstract] [Full Text] [Related]

  • 11. Evidence for the up-regulation of kappa opiate mechanisms in mice selectively bred for high analgesia.
    Kest B, Mogil JS, Sternberg WF, Liebeskind JC, Sadowski B.
    Proc West Pharmacol Soc; 1993 Mar 21; 36():249-53. PubMed ID: 8397420
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity.
    Caroleo MC, Arbitrio M, Melchiorri D, Nisticò G.
    Neuroimmunomodulation; 1994 Mar 21; 1(2):141-7. PubMed ID: 7489325
    [Abstract] [Full Text] [Related]

  • 14. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS, Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1991 Jan 21; 256(1):149-58. PubMed ID: 1846412
    [Abstract] [Full Text] [Related]

  • 15. Opioids disrupt Ca2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro: transient increases and adaptation to sustained exposure.
    Hauser KF, Harris-White ME, Jackson JA, Opanashuk LA, Carney JM.
    Exp Neurol; 1998 May 21; 151(1):70-6. PubMed ID: 9582255
    [Abstract] [Full Text] [Related]

  • 16. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U, Wenger F, Caliezi A, Drack E, Varga L, Halter F.
    J Pharmacol Exp Ther; 1990 Mar 21; 252(3):1324-30. PubMed ID: 1969475
    [Abstract] [Full Text] [Related]

  • 17. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA, Romanelli L, Amico MC, Valeri P.
    Br J Pharmacol; 1993 May 21; 109(1):48-52. PubMed ID: 8388301
    [Abstract] [Full Text] [Related]

  • 18. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
    Elliott K, Kest B, Man A, Kao B, Inturrisi CE.
    Neuropsychopharmacology; 1995 Dec 21; 13(4):347-56. PubMed ID: 8747759
    [Abstract] [Full Text] [Related]

  • 19. Effects of kappa-opioid receptor agonists on locomotor activity and memory processes in mice.
    Castellano C, Ammassari-Teule M, Libri V, Pavone F.
    Pol J Pharmacol Pharm; 1988 Dec 21; 40(5):507-13. PubMed ID: 2855367
    [Abstract] [Full Text] [Related]

  • 20. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL, Nayanar V, Walker JS.
    Br J Pharmacol; 1996 Aug 21; 118(7):1754-60. PubMed ID: 8842441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.